Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole

Mark Biagi, X. Tan, Tian-Shung Wu, +5

Journal of Clinical Microbiology

Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia

Mark Biagi, A. Vialichka, M. Jurkovic, +6

Antimicrobial Agents and Chemotherapy

Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia

Mark Biagi, D. Lamm, K. Meyer, +6

Antimicrobial Agents and Chemotherapy

Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens

Mark Biagi, Aisha Shajee, A. Vialichka, +3

Antimicrobial Agents and Chemotherapy

Inadequate Cerebrospinal Fluid Concentrations of Available Salvage Agents Further Impedes the Optimal Treatment of Multidrug-Resistant Enterococcus faecium Meningitis and Bacteremia

Eric Wenzler, Alina Adeel, Tiffany Wu, +6

Infectious Disease Reports

Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility

Taylor C. Abbey, A. Vialichka, M. Jurkovic, +2

Microbiology Spectrum